Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction
<p>Abstract</p> <p>Background</p> <p>The beta-1 adrenergic receptor (β<sub>1</sub>AR) plays a fundamental role in the regulation of cardiovascular functions. It carries a nonsynonymous single nucleotide polymorphism in its carboxyl terminal tail (Arg389Gly),...
Main Authors: | Hakalahti Anna E, Tapanainen Jari M, Junttila Juhani M, Kaikkonen Kari S, Huikuri Heikki V, Petäjä-Repo Ulla E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/9/1/42 |
Similar Items
-
Human β<sub>1</sub>-adrenergic receptor:biosynthesis, processing and the carboxyl-terminal polymorphism
by: Hakalahti, A. (Anna)
Published: (2011) -
Genetic contributions to the expression of acquired causes of cardiac hypertrophy in non-ischemic sudden cardiac death victims
by: Lauri Holmström, et al.
Published: (2021-05-01) -
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
by: Mohapradeep Mohan, et al.
Published: (2021-09-01) -
Persistent Aortic Stiffness and Left Ventricular Hypertrophy in Children of Diabetic Mothers
by: Victor Do, MD, et al.
Published: (2021-03-01) -
Beta-adrenergic pathway in healthy and hypertrophied hearts
by: Reginaldo de Almeida Barros, et al.
Published: (1999-05-01)